retatrutide phase 2 trial results obesity New 3 trials came out and the are impressive: - 1,152 patients with obesity & type diabetes retatrutide weight loss phase 2

In vitro studies indicated that those drugs are substrates of drug transporters such as SLC22A6 (ibuprofen and methotrexate), SLC22A7 (methotrexate), SLC22A8 (ibuprofen and methotrexate), SLC22A11 (ibuprofen and methotrexate), SLCO1B3 (methotrexate), PCFT (methotrexate), RFC (methotrexate) and ABC transporters (carbamazepine) 27,28,29,30,31

START YOUR HEALTH TRANSFORMATION Your well-being is our priority

No authorised GB nutrition or health claims exist for L-carnitine in relation to weight loss or fat metabolism

Last reviewed: July 12, 2026 Last updated: July 12, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations